Semaglutide for weight loss in people with obesity as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life

Br J Dermatol. 2024 Sep 18;191(4):631-633. doi: 10.1093/bjd/ljae216.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Female
  • Glucagon-Like Peptides* / administration & dosage
  • Glucagon-Like Peptides* / therapeutic use
  • Hidradenitis Suppurativa* / complications
  • Hidradenitis Suppurativa* / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Obesity* / complications
  • Obesity* / drug therapy
  • Quality of Life*
  • Treatment Outcome
  • Weight Loss* / drug effects

Substances

  • semaglutide
  • Glucagon-Like Peptides